Syros(SYRS) - 2021 Q4 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2021 Financial Results Conference Call March 15, 2022 8:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications and Investor Relations Nancy Simonian - Chief Executive Officer Jason Haas - Chief Financial Officer David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conley Chee - Chief Commercial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Phil Nadeau - ...